128 related articles for article (PubMed ID: 26235741)
1. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid inhibits aromatase activity and phosphorylation: potential mechanism for additive zoledronic acid and letrozole drug interaction.
Schech AJ; Nemieboka BE; Brodie AH
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):195-202. PubMed ID: 22659283
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation.
Hahm ER; Kim SH; Pore SK; Mathan SV; Singh RP; Singh SV
Mol Carcinog; 2024 Feb; 63(2):301-313. PubMed ID: 37921547
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages.
Tsagozis P; Eriksson F; Pisa P
Cancer Immunol Immunother; 2008 Oct; 57(10):1451-9. PubMed ID: 18297280
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay.
Fehm T; Zwirner M; Wallwiener D; Seeger H; Neubauer H
BMC Cancer; 2012 Jul; 12():308. PubMed ID: 22824103
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effect of zoledronic acid in endocrine-resistant breast cancer cells via HER-2 signaling.
Adchariyasakulchai P; Sakunrangsit N; Chokyakorn S; Suksanong C; Ketchart W
Biomed Pharmacother; 2024 Feb; 171():116142. PubMed ID: 38198953
[TBL] [Abstract][Full Text] [Related]
7. Standardized
Wiziack Zago PM; Oliveira Sousa IM; Servat-Medina L; Jorge MP; Lima Neto LG; Hass V; Li X; Tasca Gois Ruiz AL; Saxena D; Foglio MA
Clin Cosmet Investig Dent; 2020; 12():327-333. PubMed ID: 32848479
[TBL] [Abstract][Full Text] [Related]
8. Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation.
Singhatanadgit W; Hankamolsiri W; Janvikul W
R Soc Open Sci; 2021 Jun; 8(6):202066. PubMed ID: 34113452
[TBL] [Abstract][Full Text] [Related]
9. Piperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer.
Mitra S; Biswas P; Bandyopadhyay A; Gadekar VS; Gopalakrishnan AV; Kumar M; Radha ; Nandy S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; ():. PubMed ID: 37955690
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
Zhang S; Zhang C; Liu W; Zheng W; Zhang Y; Wang S; Huang D; Liu X; Bai Z
Int J Oncol; 2015 Oct; 47(4):1351-60. PubMed ID: 26252200
[TBL] [Abstract][Full Text] [Related]
11. miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2.
Chen Z; Li Q; Wang S; Zhang J
Int J Mol Med; 2015 Oct; 36(4):1136-42. PubMed ID: 26239806
[TBL] [Abstract][Full Text] [Related]
12. Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro.
Chiang IT; Wang WS; Liu HC; Yang ST; Tang NY; Chung JG
Oncol Rep; 2015 Oct; 34(4):1853-74. PubMed ID: 26238775
[TBL] [Abstract][Full Text] [Related]
13. Synergistic, cytotoxic and apoptotic activities of olmesartan with NF-κB inhibitor against HeLa human cell line.
Bakhtiari E; Hosseini A; Boroushaki MT; Mousavi SH
Toxicol Mech Methods; 2015; 25(8):614-21. PubMed ID: 26330000
[TBL] [Abstract][Full Text] [Related]
14. Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions.
Yan W; Tu B; Liu YY; Wang TY; Qiao H; Zhai ZJ; Li HW; Tang TT
Bone Res; 2013 Dec; 1(4):362-70. PubMed ID: 26273514
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
16. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
17. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan.
Ji HX; Chang WS; Tsai CW; Wang JY; Huang NK; Lee AS; Shen MY; Chen WY; Chiang YC; Shih TC; Hsu CM; Bau DT
Anticancer Res; 2015 Sep; 35(9):4975-81. PubMed ID: 26254397
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4.
Jin Y; Zhao M; Xie Q; Zhang H; Wang Q; Ma Q
Int J Oncol; 2015 Oct; 47(4):1594-602. PubMed ID: 26252944
[TBL] [Abstract][Full Text] [Related]
19. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with ovarian cancer susceptibility.
Yan S; Yuan C; Yang Q; Li X; Yang N; Liu X; Dong R; Zhang X; Yuan Z; Zhang N; Kong B
Oncol Rep; 2015 Oct; 34(4):2151-5. PubMed ID: 26252839
[TBL] [Abstract][Full Text] [Related]
20. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.
Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S
Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
